Siemens and Dräger are expanding their partnership

Drägerwerk AGDräger acquires 10 percent of Siemens AG shares in its Joint Venture Dräger Medical AG & Co. KG for a sales price of approximately 110 million EUR and increases its stake to 75 percent. At the same time, Siemens AG waves the sales option of its shares originally agreed in the Joint Venture contract and retains its 25 percent holding in the Dräger Medical Group. In addition, Siemens AG plans to purchase 2.5 percent of the Drägerwerk AG, probably in the form of common stock to be issued in the future.

"With an investment in Drägerwerk AG, we document that we want to intensify and continue our partnership," emphasizes Erich R. Reinhardt, member of the Executive Board of Siemens AG and CEO and President of Siemens Medical Solutions. "We have reached an excellent competitive position and are growing faster than the market," added Stefan Dräger, Chairman of Drägerwerk AG. Both companies have contributed to the development of Dräger Medical into one of the leading international manufacturers of medical therapy systems.

In 2003, Drägerwerk AG and Siemens AG founded the Joint Venture Dräger Medical AG & Co. KG, Lübeck. For fiscal year 2006, the total number of employees was at approximately 6,000, and sales of approx. 1.2 billion EUR and an EBIT of approximately 110 million EUR is expected.

Drägerwerk AG is an international leader in the markets for medical and safety technology. In 2005, this technology group generated sales of €1,630.8 million. Founded in 1889, Dräger, Lübeck, nowadays employs around 9,700 people in more than 190 countries, hereof more than 50 percent outside of Germany. The Dräger Medical subgroup offers products and services plus integrated system solutions along the entire patient process chain in the CareAreas™ emergency care, perioperative care, critical and perinatal care, as well as home care. The Dräger Safety subgroup's portfolio covers products and system solutions for holistic hazard management: gas detection, personal and property protection products including a wide variety of services. For further information, visit www.draeger.com.

Most Popular Now

Most Advanced Artificial Touch for Brain…

For the first time ever, a complex sense of touch for individuals living with spinal cord injuries is a step closer to reality. A new study published in Science, paves...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

Using AI to Uncover Hospital Patients�…

Across the United States, no hospital is the same. Equipment, staffing, technical capabilities, and patient populations can all differ. So, while the profiles developed for people with common conditions may...

New AI Tool Uses Routine Blood Tests to …

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors - a type of...

New Method Tracks the 'Learning Cur…

Introducing Annotatability - a powerful new framework to address a major challenge in biological research by examining how artificial neural networks learn to label genomic data. Genomic datasets often contain...

Picking the Right Doctor? AI could Help

Years ago, as she sat in waiting rooms, Maytal Saar-Tsechansky began to wonder how people chose a good doctor when they had no way of knowing a doctor's track record...

From Text to Structured Information Secu…

Artificial intelligence (AI) and above all large language models (LLMs), which also form the basis for ChatGPT, are increasingly in demand in hospitals. However, patient data must always be protected...

AI Innovation Unlocks Non-Surgical Way t…

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI scans, offering insights into patients’ cancer without aggressive surgery. The proof-of-concept study, co-led...

Deep Learning Model Helps Detect Lung Tu…

A new deep learning model shows promise in detecting and segmenting lung tumors, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA)...

New Study Reveals AI's Transformati…

Intensive care units (ICUs) face mounting pressure to effectively manage resources while delivering optimal patient care. Groundbreaking research published in the INFORMS journal Information Systems Research highlights how a novel...

One of the Largest Global Surveys of Soc…

As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of Bayer, and Boston Consulting Group (BCG) announced the launch...